- An over-the-counter lateral flow immunoassay is designed for the rapid qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in anterior nasal swab specimens
Uses
- Symptomatic Testing:
- Used to detect active COVID-19 infections in individuals showing symptoms, ideally within the first 5 to 6 days of symptom onset
- Asymptomatic Screening:
- Used for serial screening (testing multiple times over a few days) in individuals without symptoms to rule out infection
Features
- Rapid 10-Minute Results:
- Delivers clear, visually read results in just 10 minutes without the need for lab equipment or an analyzer
- Gentle Nasal Swab:
- Uses a non-invasive, shallow anterior nasal swab (about ½ to ¾ of an inch deep) for comfortable self-collection
- Pre-Filled Reagent Tubes:
- Contains pre-filled tubes with the liquid solution to minimize procedural errors, prevent spills, and skip manual drop-counting
- Simple "Dip and Read" Format:
- Requires only a few simple steps—swab, swirl, dip the test strip, and read the colors in the result window
- Companion App Support:
- Pairs with the QVUE companion app for iOS and Android, which provides animated step-by-step instructions, built-in test timers, and shareable digital results
- User-Friendly:
- Authorized for non-prescription home use by individuals aged 14 and older, and for testing children aged 2 and older with adult assistance
Benefits
- Convenience and Privacy:
- Allows you to test yourself or family members from the comfort of your own home, making it easy to screen before attending social gatherings, returning to work, or traveling
- Limit Spread of Disease:
- Rapid identification of positive cases allows individuals to isolate and take early action to protect vulnerable family members and contacts
- Cost-Effective:
- A more affordable, accessible alternative to lab-based PCR testing while offering dependable reliability for everyday monitoring
- Reliable Accuracy:
- Clinical studies have demonstrated this test correctly identifies negative cases approximately 99.1% of the time and positive cases 82.0% of the time